Cargando…
Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases
The last few decades have witnessed an increased life expectancy of patients suffering with systemic rheumatic diseases, mainly due to improved management, advanced therapies and preventative measures. However, autoimmune disorders are associated with significantly enhanced cardiovascular morbidity...
Autores principales: | Dimitroulas, Theodoros, Sandoo, Aamer, Kitas, George D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497274/ https://www.ncbi.nlm.nih.gov/pubmed/23202900 http://dx.doi.org/10.3390/ijms131012315 |
Ejemplares similares
-
Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation
por: Dimitroulas, Theodoros, et al.
Publicado: (2017) -
Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study
por: Dimitroulas, Theodoros, et al.
Publicado: (2015) -
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010) -
Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism
por: Matrozova, Joanna, et al.
Publicado: (2016) -
Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)